Related Experiment Video
Updated: Jun 29, 2026
07:08
Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
Published on: February 2, 2024
Challenges in developing targeted therapy for pancreatic adenocarcinoma
Devalingam Mahalingam1, Francis Giles
1Institute of Drug Development, Division of Hematology and Medical Oncology, University of Texas Health Science Centre, San Antonio, Texas 78229, USA.
Expert Opinion on Therapeutic Targets
|October 15, 2008
Summary
Pancreatic cancer
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Pancreatic adenocarcinoma is a significant cause of cancer mortality in the US.
- Gemcitabine-based chemotherapy is the standard treatment for advanced pancreatic cancer.
- Understanding molecular pathogenesis is key to improving outcomes.
Purpose of the Study:
- To detail the molecular heterogeneity of pancreatic cancers.
- To review emerging targeted therapies.
- To discuss challenges in pancreatic cancer treatment.
Main Methods:
- Literature review of PubMed.
- Analysis of clinical trial databases (clinicaltrials.gov).
- Inclusion of data from ASCO and AACR meetings.
Main Results:
- Pancreatic cancer pathogenesis involves multiple complex pathways and mutations.
- Significant molecular heterogeneity exists within pancreatic tumors.
- Current targeted therapies face challenges due to this heterogeneity.
Conclusions:
- Targeting multiple oncogenic pathways is crucial for improving survival.
- Novel targeted therapies are needed to overcome treatment resistance.
- Addressing molecular heterogeneity is essential for advancing pancreatic cancer treatment.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...